Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

China Health Group Inc. (8225) Stock Price & Analysis

0 Followers

8225 Stock Chart & Stats

HK$0.06HK$0.00(0.00%)
At close: 4:00 PM GMT+8
HK$0.06HK$0.07HK$0.08Aug 24Aug 28Sep 18Oct 5Oct 21Nov 4
Day’s Range
HKD 0.06 - HKD 0.08
52-Week Range
HKD 0.06 - HKD 0.17
Previous Close
HKD 0.06
Volume
N/A
Average Volume (3M)
105.33K
Market Cap
HKD 59.72M
Enterprise Value
HKD 52.71M
Total Cash (Recent Filing)
HKD 25.16M
Total Debt (Recent Filing)
HKD 0
Price to Earnings (P/E)
―
Beta
0.15
Next Earnings
Mar 30, 2027 (Est.)
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

No Reported Debt

The absence of reported debt limits interest obligations and refinancing exposure, giving the company greater financial flexibility than a highly leveraged peer. This cushion can help preserve resources for operations and investment even while profitability remains weak.

Improved Cash Generation

Positive operating cash flow across 2023–2025 and positive free cash flow in 2024–2025 indicate improved cash discipline despite accounting losses. Sustained internally generated cash would support ongoing operations without relying as heavily on external financing.

Higher Gross Margin

The substantial gross-margin improvement shows that the economics of revenue generation strengthened in 2025. If maintained, a higher gross margin could provide more contribution toward operating costs and improve the company’s ability to convert revenue into future earnings.

Bears Say

Persistent Net Losses

Multi-year losses indicate that the business has not yet demonstrated a sustainable earnings model. A TTM net margin near -52% means revenue is currently insufficient to cover the full cost base, limiting reinvestment capacity and increasing pressure on the capital base.

Eroding Equity Base

Repeated losses have materially reduced shareholders’ equity, weakening the balance-sheet foundation even though reported debt is absent. Negative recent return on equity signals that the capital committed to the business is not currently producing acceptable returns or strengthening financial resources.

Volatile Free Cash Flow

Recent positive cash flow is tempered by a sharp 2025 free-cash-flow decline and a history of negative operating cash flow. This volatility makes internally funded growth less dependable and raises the risk that future operations may require balance-sheet resources or external capital.

8225 FAQ

What was China Health Group Inc.’s price range in the past 12 months?
China Health Group Inc. lowest stock price was HK$0.06 and its highest was HK$0.17 in the past 12 months.
What is China Health Group Inc.’s market cap?
China Health Group Inc.’s market cap is HK$59.72M.
When is China Health Group Inc.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were China Health Group Inc.’s earnings last quarter?
China Health Group Inc. released its earnings results on Aug 27, 2026. The company reported HK$0.011 earnings per share for the quarter.
Is China Health Group Inc. overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does China Health Group Inc. pay dividends?
China Health Group Inc. does not currently pay dividends.
What is China Health Group Inc.’s EPS estimate?
China Health Group Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does China Health Group Inc. have?
China Health Group Inc. has 995,351,700 shares outstanding.
What happened to China Health Group Inc.’s price movement after its last earnings report?
China Health Group Inc. reported an EPS of HK$0.011 in its last earnings report. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of China Health Group Inc.?
Currently, no hedge funds are holding shares in HK:8225
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology